His scientific interests lie mostly in Acquired immunodeficiency syndrome, Immunology, Cohort study, Prospective cohort study and Pediatrics. George R. Seage undertakes interdisciplinary study in the fields of Acquired immunodeficiency syndrome and Quality-adjusted life year through his research. His work deals with themes such as Odds ratio, Internal medicine and Cohort, which intersect with Immunology.
He has included themes like Psychiatry, Incidence and Family medicine in his Cohort study study. As part of the same scientific family, he usually focuses on Prospective cohort study, concentrating on Pediatric AIDS and intersecting with Quality of life, Interquartile range, Proportional hazards model and Hazard ratio. His Pediatrics research focuses on Lentivirus and how it relates to Referral.
George R. Seage focuses on Acquired immunodeficiency syndrome, Immunology, Pediatrics, Cohort study and Prospective cohort study. His Acquired immunodeficiency syndrome research includes elements of Odds ratio, Viral disease, Epidemiology and Risk factor. His Immunology research incorporates themes from Internal medicine, Incidence and Virology.
Within one scientific family, he focuses on topics pertaining to Surgery under Pediatrics, and may sometimes address concerns connected to Life expectancy. His research in Cohort study intersects with topics in Young adult, Family medicine, Obstetrics, Atazanavir and Cohort. His study in Prospective cohort study is interdisciplinary in nature, drawing from both Relative risk and Pediatric AIDS.
George R. Seage mainly focuses on Cohort study, Acquired immunodeficiency syndrome, Cohort, Pediatrics and Prospective cohort study. George R. Seage interconnects Family medicine, Obstetrics, Zika virus, Reproductive medicine and Emtricitabine in the investigation of issues within Cohort study. The Acquired immunodeficiency syndrome study combines topics in areas such as Regimen, Internal medicine and Viral load.
His study in Cohort is interdisciplinary in nature, drawing from both Antiretroviral therapy, Proportional hazards model, Cumulative incidence and Confidence interval. As a part of the same scientific study, George R. Seage usually deals with the Pediatrics, concentrating on Efavirenz and frequently concerns with Microcephaly and In utero. George R. Seage combines subjects such as Guideline and Health policy with his study of Prospective cohort study.
His primary areas of study are Cohort, Acquired immunodeficiency syndrome, Cohort study, Pediatrics and Confidence interval. His Cohort research incorporates elements of Pediatric hiv, Proportional hazards model and Family medicine. George R. Seage conducted interdisciplinary study in his works that combined Acquired immunodeficiency syndrome and Millennium Development Goals.
His Cohort study study integrates concerns from other disciplines, such as Atazanavir, Epidemiology, Cumulative incidence and Emtricitabine. As part of his studies on Pediatrics, George R. Seage frequently links adjacent subjects like Prospective cohort study. His work carried out in the field of Confidence interval brings together such families of science as Breastfeeding and Interquartile range.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Essentials of Epidemiology in Public Health
Ann Aschengrau;George R. Seage.
Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
A. David Paltiel;Milton C. Weinstein;April D. Kimmel;George R. Seage.
The New England Journal of Medicine (2005)
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Kenneth A. Freedberg;Elena Losina;Milton C. Weinstein;A. David Paltiel.
The New England Journal of Medicine (2001)
The lifetime cost of current human immunodeficiency virus care in the United States.
Bruce R. Schackman;Kelly A. Gebo;Rochelle P. Walensky;Elena Losina.
Medical Care (2006)
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
Steven L. Gortmaker;Michael Hughes;Joseph Cervia;Michael Brady.
The New England Journal of Medicine (2001)
Estimating the lost benefits of antiretroviral drug use in South Africa.
Pride Chigwedere;George R Seage;Sofia Gruskin;Tun-Hou Lee.
Journal of Acquired Immune Deficiency Syndromes (2008)
Randomized Controlled Trial of Audio Computer-assisted Self-Interviewing: Utility and Acceptability in Longitudinal Studies
David S. Metzger;Beryl Koblin;Charles Turner;Helen Navaline.
American Journal of Epidemiology (2000)
Duration of human immunodeficiency virus infection before detection of antibody.
C. Robert Horsburgh;Janine Jason;Ira M. Longini;Kenneth H. Mayer.
The Lancet (1989)
Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Philimon Gona;Russell B. Van Dyke;Paige L. Williams;Wayne M. Dankner.
HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness
A. David Paltiel;Kenneth A. Freedberg;Callie A. Scott;Bruce R. Schackman.
Clinical Infectious Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: